Your browser doesn't support javascript.
loading
COVID-19 management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases centre: a detailed descriptive analysis
Kenneth F. Baker; Aidan T. Hanrath; Ina Schim van der Loeff; Su Ann Tee; Richard Capstick; Gabriella Marchitelli; Ang Li; Andrew Barr; Alsafi Eid; Sajeel Ahmed; Dalvir Bajwa; Omer Mohammed; Neil Alderson; Clare Lendrem; Dennis Lendrem; COVID-19 Control Group; COVID-19 Clinical Group; Lucia Pareja-Cebrian; Andrew Welch; Joanne Field; Brendan A.I. Payne; Yusri Taha; David A. Price; Christopher Gibbins; Matthias L. Schmid; Ewan Hunter; Christopher J.A. Duncan.
Afiliación
  • Kenneth F. Baker; Translational and Clinical Research Institute, Newcastle University, UK
  • Aidan T. Hanrath; Translational and Clinical Research Institute, Newcastle University, UK
  • Ina Schim van der Loeff; Translational and Clinical Research Institute, Newcastle University, UK
  • Su Ann Tee; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Richard Capstick; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Gabriella Marchitelli; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Ang Li; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Andrew Barr; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Alsafi Eid; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Sajeel Ahmed; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Dalvir Bajwa; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Omer Mohammed; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Neil Alderson; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Clare Lendrem; NIHR In Vitro Diagnostics Cooperative, Newcastle University, UK
  • Dennis Lendrem; National Institute of Health Research (NIHR) Biomedical Research Centre, Newcastle University, UK
  • COVID-19 Control Group;
  • COVID-19 Clinical Group;
  • Lucia Pareja-Cebrian; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Andrew Welch; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Joanne Field; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Brendan A.I. Payne; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Yusri Taha; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • David A. Price; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Christopher Gibbins; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Matthias L. Schmid; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Ewan Hunter; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  • Christopher J.A. Duncan; Translational and Clinical Research Institute, Newcastle University, UK
Preprint en En | PREPRINT-MEDRXIV | ID: ppmedrxiv-20100834
ABSTRACT
BackgroundRecent large national and international cohorts describe the baseline characteristics and outcome of hospitalised patients with COVID-19, however there is little granularity to these reports. We aimed to provide a detailed description of a UK COVID-19 cohort, focusing on clinical decisions and patient journeys. MethodsWe retrospectively analysed the management and 28-day outcomes of 316 consecutive adult patients with SARS-CoV-2 PCR-confirmed COVID-19 admitted to a large NHS Foundation Trust with a tertiary High Consequence Infectious Diseases centre in the North of England. FindingsMost patients were elderly (median age 75) with multiple comorbidities. One quarter were admitted from residential or nursing care. Symptoms were consistent with COVID-19, with cough, fever and/or breathlessness in 90.5% of patients. Two thirds of patients had severe disease on admission. Mortality was 81/291 (27.8%). Most deaths were anticipated; decisions to initiate respiratory support were individualised after consideration of patient wishes, premorbid frailty and comorbidities, with specialist palliative care input where appropriate. 22/291 (7.6%) patients were intubated and 11/22 (50%) survived beyond discharge. Multiple logistic regression identified age as the most significant risk factor for death (OR 1.09 [95% CI 1.06 - 1.12] per year increase, p < 0.001). InterpretationThese findings provide important clinical context to outcome data. Deaths were anticipated, occurring in patients with advance decisions on ceilings of treatment. Age was the most significant risk factor for death, confirming that demographic factors in the population are a major influence on hospital mortality rates. FundingFunding was not required.
Licencia
cc_no
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Cohort_studies / Observational_studies / Prognostic_studies Idioma: En Año: 2020 Tipo del documento: Preprint
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Cohort_studies / Observational_studies / Prognostic_studies Idioma: En Año: 2020 Tipo del documento: Preprint